1887

Chapter 116 : Evaluation of the Cellular Immune Response in Transplantation

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Evaluation of the Cellular Immune Response in Transplantation, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH116-1.gif /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH116-2.gif

Abstract:

Solid-organ transplantation has become an increasingly important therapeutic modality for patients with various end-stage diseases. Despite improved immunosuppression protocols, most transplant recipients face a variety of complications. Early posttransplant infection and rejection are the major causes of morbidity and mortality. Drug toxicity, chronic rejection, and malignancies are long-term complications.

Citation: Metes D, Reinsmoen N, Zeevi A. 2016. Evaluation of the Cellular Immune Response in Transplantation, p 1108-1122. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch116
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818722.ch116
1. Bach F, Hirschhorn K. 1964. Lymphocyte interaction: a potential histocompatibility test in vitro. Science 143:813814.[PubMed].[CrossRef]
2. Bain B, Vas MR, Lowenstein L. 1964. The development of large immature mononuclear cells in mixed leukocyte cultures. Blood 23:108116.[PubMed]
3. Reinsmoen NL, Kaufman D, Matas A, Sutherland DE, Najarian JS, Bach FH. 1990. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients. Transplantation 50:783790.[PubMed].[CrossRef]
4. Reinsmoen NL, Matas AJ. 1993. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 55:10171023.[PubMed].[CrossRef]
5. Reinsmoen NL, Mickelson EM,. 1994. HLA-DW typing, p II.C.3.1II.C.3.9 In Nikaein A (ed), American Society for Histocompatibility and Immunogenetics Procedure Manual. ASHI, Mount Laurel, NJ.
6. VanBuskirk AM, Adams PW, Orosz CG. 1995. Nonradioactive alternative to clinical mixed lymphocyte reaction. Hum Immunol 43:3844.[PubMed].[CrossRef]
7. Kaminski E, Hows J, Brookes P, Mackinnon S, Hughes T, Avakian O, Sharrock C, Goldman J, Batchelor JR. 1989. Alloreactive cytotoxic T-cell frequency analysis and HLA matching for bone marrow transplants from HLA matched unrelated donors. Transplant Proc 21:29762977.[PubMed]
8. Kaminski E, Hows J, Man S, Brookes P, Mackinnon S, Hughes T, Avakian O, Goldman JM, Batchelor JR. 1989. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 48:608613.[PubMed]
9. van Besouw NM, van der Mast BJ, de Kuiper P, Smak Gregoor PJ, Vaessen LM, IJzermans JN, van Gelder T, Weimar W. 2000. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 70:136143.[PubMed]
10. Macedo C, Orkis EA, Popescu I, Elinoff BD, Zeevi A, Shapiro R, Lakkis FG, Metes D. 2009. Contribution of naive and memory T-cell populations to the human alloimmune response. Am J Transplant 9:20572066.[CrossRef].[PubMed]
11. Macedo C, Walters JT, Orkis EA, Isse K, Elinoff BD, Fedorek SP, McMichael JM, Chalasani G, Randhawa P, Demetris AJ, Zeevi A, Tan H, Shapiro R, Landsittel D, Lakkis FG, Metes D. 2012. Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation. Transplantation 93:813821.[CrossRef]
12. Parish CR, Glidden MH, Quah BJ, Warren HS. 2009. Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. Curr Protoc Immunol Chapter 4:Unit4.9.
13. Wells AD, Walsh MC, Sankaran D, Turka LA. 2000. T cell effector function and anergy avoidance are quantitatively linked to cell division. J Immunol 165:24322443.[PubMed].[CrossRef]
14. Fung JJ, Zeevi A, Markus B, Zerbe TR, Duquesnoy RJ. 1986. Dynamics of allospecific T lymphocyte infiltration in vascularized human allografts. Immunol Res 5:149163.[PubMed].[CrossRef]
15. Shearer GM, Clerici M. 1994. In vitro analysis of cell-mediated immunity: clinical relevance. Clin Chem 40:21622165.[PubMed]
16. Zeevi A, Fung J, Zerbe TR, Kaufman C, Rabin BS, Griffith BP, Hardesty RL, Duquesnoy RJ. 1986. Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation 41:620626.[CrossRef]
17. Mayer TG, Fuller AA, Fuller TC, Lazarovits AI, Boyle LA, Kurnick JT. 1985. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. J Immunol 134:258264.[PubMed]
18. Miceli C, Metzgar RS, Chedid M, Ward F, Finn OJ. 1985. Long-term culture and characterization of alloreactive T-cell infiltrates from renal needle biopsies. Hum Immunol 14:295304.[PubMed].[CrossRef]
19. Kaufman CL, Zeevi A, Kormos RL, Zerbe TR, Keenan RJ, Uretsky BF, Griffith BP, Hardesty RL, Duquesnoy RJ. 1990. Propagation of infiltrating lymphocytes and graft coronary disease in cardiac transplant recipients. Hum Immunol 28:228236.[PubMed].[CrossRef]
20. Weber T, Kaufman C, Zeevi A, Zerbe TR, Hardesty RJ, Kormos RH, Griffith BP, Duquesnoy RJ. 1989. Lymphocyte growth from cardiac allograft biopsy specimens with no or minimal cellular infiltrates: association with subsequent rejection episode. J Heart Transplant 8:233240.[PubMed]
21. Mosmann TR, Coffman RL. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 46:111147.[PubMed].[CrossRef]
22. Kirk AD, Ibrahim MA, Bollinger RR, Dawson DV, Finn OJ. 1992. Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance. Transplantation 53:329338.[PubMed].[CrossRef]
23. Del Prete GF, De Carli M, Ricci M, Romagnani S. 1991. Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity. J Exp Med 174:809813.[PubMed].[CrossRef]
24. Walsh KP, Mills KH. 2013. Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol 34:521530.[CrossRef].[PubMed]
25. Heeger PS, Greenspan NS, Kuhlenschmidt S, Dejelo C, Hricik DE, Schulak JA, Tary-Lehmann M. 1999. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 163:22672275.[PubMed]
26. Ahmed M, Venkataraman R, Logar AJ, Rao AS, Bartley GP, Robert K, Dodson FS, Shapiro R, Fung JJ, Zeevi A. 2001. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(−) and CD8(+) peripheral blood T cells. Ther Drug Monit 23:354362.[PubMed].[CrossRef]
27. Ferry B, Antrobus P, Huzicka I, Farrell A, Lane A, Chapel H. 1997. Intracellular cytokine expression in whole blood preparations from normals and patients with atopic dermatitis. Clin Exp Immunol 110:410417.[PubMed].[CrossRef]
28. Sewell WA, North ME, Webster AD, Farrant J. 1997. Determination of intracellular cytokines by flow-cytometry following whole-blood culture. J Immunol Methods 209:6774.[PubMed].[CrossRef]
29. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. 1993. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159:197207.[PubMed].[CrossRef]
30. Korin YD, Lee C, Gjertson DW, Wilkinson AH, Pham TP, Danovitch GM, Gritsch HA, Reed EF. 2005. A novel flow assay for the detection of cytokine secreting alloreactive T cells: application to immune monitoring. Hum Immunol 66:11101124.[CrossRef].[PubMed]
31. McNeil LK, Price L, Britten CM, Jaimes M, Maecker H, Odunsi K, Matsuzaki J, Staats JS, Thorpe J, Yuan J, Janetzki S. 2013. A harmonized approach to intracellular cytokine staining gating: results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI). Cytometry Part A 83:728738.
32. Britten CM, Janetzki S, Butterfield LH, Ferrari G, Gouttefangeas C, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief CJ, O'Donnell-Tormey J, Odunsi K, Old LJ, Ottenhoff TH, Ottensmeier C, Pawelec G, Roederer M, Roep BO, Romero P, van der Burg SH, Walter S, Hoos A, Davis MM. 2012. T cell assays and MIATA: the essential minimum for maximum impact. Immunity 37:12.[CrossRef].[PubMed]
33. Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, Furlong J, Gasparetto M, Goldberg M, Goralczyk EM, Hyun B, Jansen K, Kollmann T, Kong M, Leif R, McWeeney S, Moloshok TD, Moore W, Nolan G, Nolan J, Nikolich-Zugich J, Parrish D, Purcell B, Qian Y, Selvaraj B, Smith C, Tchuvatkina O, Wertheimer A, Wilkinson P, Wilson C, Wood J, Zigon R, International Society for Advancement of Cytometry Data Standards Task Force, Scheuermann RH, Brinkman RR 2008. MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry Part A 73:926930.
34. Sottong PR, Rosebrock JA, Britz JA, Kramer TR. 2000. Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP. Clin Diagn Lab Immunol 7:307311.[PubMed]
35. Buttgereit F, Burmester GR, Brand MD. 2000. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol Today 21:192199.[PubMed]
36. Schulick RD, Weir MB, Miller MW, Cohen DJ, Bermas BL, Shearer GM. 1993. Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs. Transplantation 56:590596.[PubMed]
37. Zeevi A, Kaufman C, Duquesnoy R,. 1994. Clinical relevance of lymphocyte analysis in cardiac and pulmonary transplantation, p 181199. In Rose ML, Yacoub MH (ed), Immunology of Heart and Lung Transplantation. Edward Arnold Publisher, London, United Kingdom.
38. Schwarer AP, Jiang YZ, Deacock S, Brookes PA, Barrett AJ, Goldman JM, Batchelor JR, Lechler RI. 1994. Comparison of helper and cytotoxic antirecipient T cell frequencies in unrelated bone marrow transplantation. Transplantation 58:11981203.[PubMed]
39. Kowalski R, Post D, Schneider MC, Britz J, Thomas J, Deierhoi M, Lobashevsky A, Redfield R, Schweitzer E, Heredia A, Reardon E, Davis C, Bentlejewski C, Fung J, Shapiro R, Zeevi A. 2003. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 17:7788.[PubMed].[CrossRef]
40. Zeevi A, Britz JA, Bentlejewski CA, Guaspari D, Tong W, Bond G, Murase N, Harris C, Zak M, Martin D, Post DR, Kowalski RJ, Elmagd KA. 2005. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. Transpl Immunol 15:1724.[CrossRef].[PubMed]
41. Rodrigo E, Lopez-Hoyos M, Corral M, Fabrega E, Fernandez-Fresnedo G, San Segundo D, Pinera C, Arias M. 2012. ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis. Liver Transplant 18:12451253.

Tables

Generic image for table
TABLE 1

Interpretation of PHA-stimulated sample

Citation: Metes D, Reinsmoen N, Zeevi A. 2016. Evaluation of the Cellular Immune Response in Transplantation, p 1108-1122. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch116
Generic image for table
TABLE 2

Distribution of results of the Cylex immune cell function assay

Citation: Metes D, Reinsmoen N, Zeevi A. 2016. Evaluation of the Cellular Immune Response in Transplantation, p 1108-1122. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch116

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error